Use of herbal medicines and nutritional supplements in ocular disorders: An evidence-based review

Drugs

Volumn 71, Issue 18, 2011, Pages 2421-2434

  Wilkinson, Justin T ^a   Fraunfelder, Frederick W ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Casey Eye Institute and the National Registry of Drug Induced Ocular Side Effects   (United States)

Author keywords

Age related macular degeneration; Cataracts; Diabetic retinopathy; Eye disorders; Ginkgo biloba; Glaucoma; Guar gum; Hamamelis; Herbal medicines; Marijuana; Vaccinium myrtillus

Indexed keywords

5 HYDROXYTRYPTOPHAN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CANNABIS; CANTHAXANTHIN; CENTRUM; CHAMOMILE; CHRYSAROBIN; COPPER; CYANOCOBALAMIN; DIMETHYL SULFOXIDE; HERBACEOUS AGENT; HUPERZINE A; HYDROXYCUT; ISOFLAVONE; ISPAGULA; KAVA; MANNITOL; NICOTINIC ACID; OMEGA 3 FATTY ACID; PLACEBO; PROPOLIS; RETINOL; SUPEROXIDE DISMUTASE; TRIAMCINOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN B GROUP; XANTHOPHYLL; ZEAXANTHIN; ZINC;

ACCOMMODATION DISORDER; AESCULUS HIPPOCASTANUM; AMMI VISNAGA; ANEMIA; ANGINA PECTORIS; ANISE; APPENDICITIS; ARCTOSTAPHYLOS UVA URSI; ARTEMISIA; ARTHRITIS; ASTHMA; ATROPA BELLADONNA; BLURRED VISION; BRAIN VASOSPASM; BRONCHITIS; BURN; CARDIOVASCULAR DISEASE; CATARACT; CATARACT EXTRACTION; CELERY; CEREBROVASCULAR DISEASE; CESTRUM; CHLORELLA; CLINICAL TRIAL (TOPIC); COMMON COLD; CONJUNCTIVITIS; CONSTIPATION; CONTROLLED CLINICAL TRIAL (TOPIC); CONVALLARIA; CORNEA DISEASE; COUGHING; DATURA; DATURA STRAMONIUM; DEMENTIA; DIABETES MELLITUS; DIABETIC RETINOPATHY; DICTAMNUS; DIET SUPPLEMENTATION; DIPLOPIA; DOUBLE BLIND PROCEDURE; DRUG FATALITY; DRUG MEGADOSE; DRUG WITHDRAWAL; DRY EYE; ECHINACEA; ECHINACEA PURPUREA; ELECTRORETINOGRAPHY; EPIPHORA; EUPHORBIA; EXOPHTHALMOS; EYE BURNING; EYE DISEASE; EYE INFLAMMATION; EYE IRRITATION; EYE MOVEMENT DISORDER; EYE SWELLING; EYELID EDEMA; FEVER; GARCINIA CAMBOGIA; GASTROINTESTINAL SYMPTOM; GELSEMIUM; GEOGRAPHIC ATROPHY; GINKGO BILOBA; GLAUCOMA; GLYCYRRHIZA; GLYCYRRHIZA GLABRA; GUAR; GYMNEMA SYLVESTRE; HAMAMELIS; HEART FAILURE; HEPATITIS C; HERACLEUM; HERBAL MEDICINE; HUMAN; HYOSCYAMUS; HYPERICUM PERFORATUM; HYPERTENSION; HYPHEMA; INDIGESTION; INFLAMMATION; INFLUENZA; INSOMNIA; INTRACRANIAL HYPERTENSION; LEVISTICUM; MANDRAGORA; MARIGOLD; MATRICARIA; MEDLINE; META ANALYSIS (TOPIC); MIGRAINE; MIOSIS; MUSCLE HYPERTONIA; MYDRIASIS; MYROXYLON; NATIONAL HEALTH ORGANIZATION; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PARIS QUADRIFOLIA; PARSNIP; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PHOTOSENSITIVITY; PHOTOTOXICITY; PILOCARPUS; PIPER METHYSTICUM; PUBLIC HEALTH SERVICE; PUNCTATE KERATITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA HEMORRHAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RETINA MACULOPATHY; RETINOPATHY; RETROBULBAR HEMORRHAGE; REVIEW; RUTACEAE; SABAL; SALVIA MILTIORRHIZA; SCHIZOPHRENIA; SCOPOLIA; SEXUAL DYSFUNCTION; SOUR ORANGE; STROPHANTHUS; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC DISEASE; TEA; TINNITUS; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; UROGENITAL TRACT DISEASE; UVEITIS; VACCINIUM MYRTILLUS; VALERIANA OFFICINALIS; VISUAL DISORDER; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION; WORLD HEALTH ORGANIZATION;

EID: 82955169566     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11596840-000000000-00000     Document Type: Review

References (101)

1. National Center for Complementary and Alternative Medicine. What is complementary and alternative medicine (CAM)? National Institutes of Health [online]. Available from URL: http://nccam.nih.gov/health/wha tiscam/[Accessed 2011 Apr 27]
2. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 289: 1569-75 (Pubitemid 28520643)
3. Tindle HA, Davis RB, Phillips RS, et al. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 2005; 11: 42-9 (Pubitemid 40110627)
4. Nahin RL, Barnes PM, Stussman BJ, et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. National Health Statistics Reports, No. 18. Hyattsville (MD): National Center for Health Statistics, 2009
5. Gahche J, Bailey R, Burt V, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS data brief, no 61. Hyattsville (MD): National Center for Health Statistics, 2011
6. Supplement business report 2010. Nutrition Business Journal. Penton Media, Inc., 2010
7. WHO guidelines on good agricultural and collection practices for medicinal plants. Geneva: WHO, 2004
8. Dharmananda S. The nature of ginseng: traditional use, modern research, and the question of dosage. Herbal Gram 2002; 54: 34-51
9. Wan MJ, Daniel S, Kassam F, et al. Survey of complementary and alternative medicine use in glaucoma patients. J Glaucoma. Epub 2010 Dec 16
10. National Eye Institute. Prevalence of blindness data: summary of eye disease prevalence data [online]. Available from URL: http://www.nei.nih.gov/ eyedata/pbd-tables. asp [Accessed 2011 Apr 27]
11. Ting AY, Lee TK, MacDonald IM. Genetics of age-related macular degeneration. Curr Opin Ophthalmol 2009; 20 (5): 369-76
12. Klein R, Peto T, Bird A, et al. The epidemiology of agerelated macular degeneration. Am J Ophthalmol 2004; 137: 486-95
13. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001; 20: 227-53 (Pubitemid 32149928)
14. Clemons TE, Milton RC, Klein R, et al., Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19. Ophthalmology 2005; 112 (4): 533-9 (Pubitemid 41108849)
15. Van den Langenberg GM, Mares-Perlman JA, Klein R, et al. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998; 148: 204-14 (Pubitemid 28334898)
16. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 2005; 294: 3101-7 (Pubitemid 43016801)
17. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417-36
18. Chew EY, Lindblad AS, Clemons T. Age-Related Eye Disease Study Research Group. Summary results and recommendations from the age-related eye disease study. Arch Ophthalmol 2009; 127 (12): 1678-9
19. Evans JR, Henshaw K. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev 2008; (1): CD000253
20. Taylor HR, Tikellis G, Robman LD, et al. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ 2002; 325: 11
21. Hodge WG, Schachter HM, Barnes D, et al. Efficacy of omega-3 fatty acids in preventing age-related macular degeneration: a systematic review. Ophthalmology 2006; 113 (7): 1165-72
22. Seif-El-Nasr M, El-Fattah AA. Lipid peroxide, phospholipids, glutathione levels and superoxide dismutase activity in rat brain after ischaemia: effect of Ginkgo biloba extract. Pharmacol Res 1995; 32: 273-8 (Pubitemid 26088197)
23. Barth SA, Inselmann G, Engemann R, et al. Influences of Ginkgo biloba on cyclosporin A induced lipid peroxidation in human liver microsomes in comparison to vitamin E, glutathione and N-acetylcysteine. Biochem Pharmacol 1991; 41: 1521-6
24. Lamant V, Mauco G, Braquet P, et al. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol 1987; 36: 2749-52 (Pubitemid 17123064)
25. Zhang J, Fu S, Liu S, et al. The therapeutic effect of Ginkgo biloba extract in SHR rats and its possible mechanisms based on cerebral microvascular flow and vasomotion. Clin Hemorheol Microcirc 2000; 23: 133-8 (Pubitemid 32274596)
26. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003; 23: 171-201 (Pubitemid 37059721)
27. Semba RD, Dagnelie G. Are lutein and zeaxanthin conditionally essential nutrients for eye health? Med Hypotheses 2003; 61: 465-72 (Pubitemid 37494484)
28. Koh HH, Murrah IJ, Nolan D, et al. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res 2004; 79: 21-7 (Pubitemid 38737379)
29. Seddom JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272: 1413-20 (Pubitemid 24328383)
30. US Food and Drug Administration. Qualified health claim: letter of denial-Xangold lutein esters, lutein, or zeaxanthin and reduced risk of age-related macular degeneration or cataract formation (docket no. 2004Q-0180) [online]. Available from URL: http://www.fda.gov/Food/LabelingNutrition/ LabelClaims/QualifiedHealthClaims/ucm073291.htm [Accessed 2011 May 7]
31. Moeller SM, Parekh N, Tinker L, et al., CAREDS Research Study Group. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol 2006; 124: 1151-62 (Pubitemid 44232345)
32. Tan JSL, Wang JJ, Flood V, et al. Dietary antioxidants and the long term incidence of age-related macular degeneration: the Blue Mountain Eye study. Ophthalmology 2008; 115: 334-41 (Pubitemid 351175680)
33. San Giovanni JP, Chew EY, Clemons TE, et al., Age-Related Eye Disease Study Research Group. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a casecontrol study: AREDS Report No. 22. Arch Ophthal 2007; 125 (9): 1225-32 (Pubitemid 47403030)
34. Javitt JC, Kendix M, Tielsch JM, et al. Geographic variation in utilization of cataract surgery. Med Care 1995; 33: 90-105
35. Escarce JJ. Would eliminating differences in physician practice style reduce geographic variations in cataract surgery rates? Med Care 1993; 31 (12): 1106-18
36. Goldzweig CL, Mittman BS, Carter GM, et al. Variations in cataract extraction rates in Medicare prepaid and feefor-service settings. JAMA 1997; 277: 1765-8 (Pubitemid 27247161)
37. Hankinson SE, Stampfer MJ, Seddon JM. Nutrient intake and cataract extraction in women: a prospective study. BMJ 1992; 305 (6849): 335-9
38. Tan AG, Mitchell P, Flood VM, et al. Antioxidant nutrient intake and the long-term incidence of age-related cataract: the Blue Mountains Eye Study. Am J Clin Nutr 2008; 87 (6): 1899-905 (Pubitemid 351872657)
39. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am J Epidemiol 1999; 149: 801-9 (Pubitemid 29196692)
40. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS Report No. 9. Arch Ophthalmol 2001; 119 (10): 1439-52
41. McNeil JJ, Robman L, Tikellis G, et al. Vitamin E supplementation and cataract: randomized controlled trial. Ophthalmology 2004; 111 (1): 75-84 (Pubitemid 38032213)
42. Teikari JM, Rautalahti M, Haukka J, et al. Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements. J Epidemiol Community Health 1998; 52: 468-72 (Pubitemid 28349717)
43. Chylack Jr LT, Brown NP, Bron A, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of and oral antioxidant micronutrient mixture to slow progression of agerelated cataract. Ophthalmic Epidemiol 2002; 9: 49-80 (Pubitemid 34098653)
44. Sperduto RD, Hu TS, Milton RC, et al. The Linxian cataract studies: two nutrition intervention trials. Arch Ophthalmol 1993; 111: 1246-53 (Pubitemid 23268787)
45. Clinical Trial of Nutritional Supplements and Age-Related Cataract Study Group, Maraini G, Sperduto RD, et al. A randomized, double-masked, placebo-controlled clinical trial of multivitamin supplementation for age-related lens opacities: clinical trial of nutritional supplements and agerelated cataract no. 3. Ophthalmology 2008; 115: 599-607
46. Christen WG, Glynn RJ, Chew EY, et al. Vitamin E and age-related cataract in a randomized trial of women. Ophthalmology 2008; 115: 822-9
47. Christen WG, Glynn RJ, Sesso HD, et al. Age-related cataract in a randomized trial of vitamins E and C in men. Arch Ophthalmol 2010; 128: 1397-405
48. Bartlett HE, Eperjesi F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthal Physiol Opt 2008; 28: 503-23
49. Lopes de Jesus CC, Atallah AN, Valente O, et al. Vitamin C and superoxide dismutase (SOD) for diabetic retinopathy. Cochrane Database Syst Rev 2008; (1): CD006695
50. Mayer-Davis EJ, Bell RA, Reboussin BA, et al. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 1998; 105: 2264-70 (Pubitemid 30191670)
51. Millen AE, Gruber M, Klein R, et al. Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2003; 158: 225-33 (Pubitemid 36944415)
52. Millen AE, Klein R, Folsom AR, et al. Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. Am J Clin Nutr 2004; 79: 865-73 (Pubitemid 41103889)
53. Huang SY, Jeng C, Kao SC, et al. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr 2004; 23 (4): 615-21 (Pubitemid 39107040)
54. Luo XX, Duan J, Liao P, et al. Effect of qiming granule on retinal blood circulation of diabetic retinopathy: a multi-center clinical trial. Chinese J Integrative Med 2009; 15 (5): 384-8
55. Sacca SC, Izzotti A. Oxidative stress and glaucoma: injury in the anterior segment of the eye. Prog Brain Research 2008; 173: 385-407
56. He Y, Leung KW, Zhang YH, et al. Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: protection by antioxidants. Invest Ophth Vis Sci 2008; 49 (4): 1447-58
57. Gunasekera V, Ernst E, Ezra DG. Systematic internetbased review of complementary and alternative medicine for glaucoma. Ophthalmology 2008; 115 (3): 435-9
58. Rhee DJ, Katz LJ, Spaeth GL, et al. Complementary and alternative medicine for glaucoma. Surv Ophthalmology 2001; 46 (1): 43-55 (Pubitemid 32781829)
59. Kang JH, Pasquale LR, Willett W, et al. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol 2003; 158: 337-46 (Pubitemid 41288801)
60. National Eye Institute, National Institutes of Health. NEI statement: the use of marijuana for glaucoma. Bethesda (MD): NEI/NIH, 1997 Feb 18
61. Merritt JC, Crawford WJ, Alexander PC, et al. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology 1980; 787: 222-8 (Pubitemid 10130590)
62. Jayle GE, AubryM,Gavini H. Study concerning the action of anthocyanoside extracts of vaccinium myrtillus on night vision. Ann Ocul 1965; 198: 556-62
63. Urso G. Effect of Vaccinium myrtillus anthocyanosides associated with beta carotenes on light sensitivity. Ann Ottalmol Clin Ocul 1967; 93: 930-8
64. Chung HS, Harris A, Kristinsson JK, et al. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther 1999; 15: 233-40 (Pubitemid 29262980)
65. Quaranta L, Bettelli S, Uva MG, et al. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003; 110: 359-62; discussion 362-4 (Pubitemid 36184342)
66. The Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group (ATBC). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029-35
67. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5 (Pubitemid 26137973)
68. Morrice Jr G, Havener WH, Kapetansky F. Vitamin A intoxication as a cause of pseudotumor cerebri. JAMA 1960; 173: 1802-5
69. Pasquariello Jr PS, Schut L, Borns P. Benign increased intracranial hypertension due to chronic vitamin A overdosage in a 26-month old child. Clin Pediatr 1977; 16: 379-82 (Pubitemid 8073686)
70. Lonn E, Bosch J, Yusuf S, et al., HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293: 1338-47 (Pubitemid 40381486)
71. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and metaanalysis. JAMA 2007; 297: 842-57 (Pubitemid 46333949)
72. Fosmire GJ. Zinc toxicity. Am J Clin Nutr 1990; 51 (2): 225-7
73. Saper RB, Rash R. Zinc: an essential micronutrient. Am Fam Physician 2009; 79 (9): 768-72
74. Cesarani A, Meloni F, Alpini D. Ginkgo biloba in the treatment of equilibrium disorders. Adv Ther 1998; 15: 291-304 (Pubitemid 28543882)
75. Le Bars PL, Katz MM, Berman N, et al. A placebocontrolled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997; 16: 1327-32 (Pubitemid 27449692)
76. Peters H, Kieser M, Holscher U. Demonstration of the efficacy of Ginkgo biloba special extract EGb 761 on intermittent claudication: a placebo-controlled, doubleblind multicenter trial. VASA 1998; 27: 106-10 (Pubitemid 28232161)
77. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 1998; 352: 36 (Pubitemid 28306571)
78. Rowin J, Lewis SL. Spontaneous bilateral subdural haematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46: 1775-6
79. Benjamin J, Muir T, Briggs K, et al. A case of cerebral haemorrhage: can Ginkgo biloba be implicated? Postgrad Med J 2001; 77: 112-3 (Pubitemid 32120982)
80. Fessenden JM, Wittenborn W, Clarke L. Ginkgo biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg 2001; 67: 33-5 (Pubitemid 33638490)
81. Fong KCS, Kinnear PE. Retrobulbar haemorrhage associated with chronic Ginkgo biloba ingestion. Postgrad Med J 2003; 79: 532-3
82. Schneider C, Bord C, Misse P, et al. Spontaneous hyphema caused by Ginkgo biloba extract. J Fr Ophthalmol 2002; 25: 731-2 (Pubitemid 36024132)
83. Fraunfelder FW. Ocular side effects fromherbalmedicines and nutritional supplements. Am J Ophthalmol 2004; 138: 639-48
84. Fraunfelder FT, Fraunfelder FW. In: Fraunfelder FT, Fraunfelder FW, editors. Drug-induced ocular side effects. 5th ed. Woburn (MA): Butterworth-Heinemann, 2001: 824
85. Phillip W. Carotenoid deposits in the retina. Klin Monatsbl Augenheilkd 1985; 187 (5): 439-40
86. Knefeli U. The 247 most beneficial plants [in Spanish]. In: War T, editor. Guia practica ilustrade de las plantas medicinales. Vol. 26. Barcelona: Blume, 1981
87. Physician's desk reference for herbal medicines. 2nd ed. Montvale (NJ): Medical Economics, 2000: 858
88. Subiza J, Subiza JL. Allergic conjunctivitis to chamomile tea. Ann Allergy 1990; 65: 127-32 (Pubitemid 20259592)
89. Chazin BJ. Effect of nicotinic acid on blood cholesterol. Geriatrics 1960; 15: 423-9
90. Parsons WB. Reduction in elevated blood cholesterol levels by large doses of nicotinic acid. JAMA 1957; 165: 234-8
91. Fraunfelder FW, Fraunfelder FT, Illingworth DR. Adverse ocular effects associated with niacin therapy. Br J Ophthalmol 1995; 79: 54-6
92. Spirn MJ,Warren FA, Guyer DR, et al. Optical coherence tomography findings in nicotinic acid maculopathy. Am J Ophthalmol 2003; 135: 913-4 (Pubitemid 36677423)
93. Dajani HM, Lauer AK. Optical coherence tomography findings in niacin maculopathy. Can J Ophthalmol 2006; 41: 197-200
94. Brinkeborn R, Shah D, Degenring F. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold: a randomized, placebo controlled, double-blind clinical trial. Phytomedicine 1999; 6: 1-6 (Pubitemid 129632486)
95. Grimm W, Muller H. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999; 106: 138-43 (Pubitemid 29115952)
96. Morgan AG, McAdam WAF, Pacsoo C, et al. Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut 1982; 23: 545-51 (Pubitemid 12119357)
97. Arase Y, Ikeda K, Murashima N, et al. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997; 79: 1494-500 (Pubitemid 27154778)
98. Barbara L, Belsasso E, Blasi A, et al. Pirenzepine and carbenozolong in gastric ulcer: preliminary results of a multicentre double-blind controlled clinical trial. Scand J Gastroenterol Suppl 1979; 57: 21-4 (Pubitemid 10167130)
99. Jun R, Zhengang W. Pharmacological research on the effect of licorice. J Tradit Chin Med 1988; 8: 307-9
100. Walker BR, Connacher AA, Webb DJ, et al. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin Sci 1992; 83: 171-8
101. Walker BR, Sang KS, Williams BC, et al. Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta. J Hypertens 1994; 12: 33-9 (Pubitemid 24044006)